<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03887715</url>
  </required_header>
  <id_info>
    <org_study_id>LND-300</org_study_id>
    <nct_id>NCT03887715</nct_id>
  </id_info>
  <brief_title>A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression</brief_title>
  <acronym>RECOVER</acronym>
  <official_title>A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>LivaNova</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>LivaNova</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objectives of this study are to determine whether active VNS Therapy treatment is superior to&#xD;
      a no stimulation control in producing a reduction in baseline depressive symptom severity,&#xD;
      based on multiple depression scale assessment tools at 12 months from randomization.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective, multi-center, randomized, controlled, blinded trial of subjects implanted with&#xD;
      VNS Therapy. Active treatment and no stimulation control are randomized, at least two weeks&#xD;
      after implantation and observed for 12-months.&#xD;
&#xD;
      After completing the 12 month endpoint in the RCT portion of the study, all RECOVER subjects&#xD;
      will transition into the prospective, open-label, longitudinal portion of the study. Subjects&#xD;
      in the control arm of RECOVER will be activated after completing the 12 month endpoint.&#xD;
&#xD;
      After completion of enrollment in the RCT portion or meeting of interim success criterion&#xD;
      (whichever comes first), up to 5,800 new subjects may enroll directly into the&#xD;
      open-label,prospective, longitudinal study. These subjects will participate in the study for&#xD;
      approximately 5 years.&#xD;
&#xD;
      The study has been designed in accordance with The Centers for Medicare and Medicaid Services&#xD;
      coverage with evidence development (CED) decision entitled &quot;Decision Memo for Vagus Nerve&#xD;
      Stimulation (VNS) for Treatment Resistant Depression (TRD) (CAG-00313R2).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 26, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2030</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>1:1 randomization of active stimulation vs. no stimulation for 12 months post randomization.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Central Rater and sponsor are blinded in the RCT phase. Sites will need to have an unblinded programmer who is only programming the device and not collecting outcomes data.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Montgomery Åsberg Depression Rating Scale (MADRS) Rate of Response</measure>
    <time_frame>12 months post randomization</time_frame>
    <description>The rate of response defined as person months of response/total months of study participation where response is at least a 50% reduction from baseline in MADRS total score. Subjects discontinuing the study before the endpoint assessment will be considered as non-responders for each successive month after discontinuance.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Montgomery Åsberg Depression Rating Scale (MADRS) Time to First response</measure>
    <time_frame>Baseline up to 12 Months</time_frame>
    <description>Time from randomization to the first observed MADRS response.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Montgomery Åsberg Depression Rating Scale (MADRS) Time to First Remission</measure>
    <time_frame>Baseline up to 12 Months</time_frame>
    <description>Time from randomization to the first observed MADRS remission.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Montgomery Åsberg Depression Rating Scale (MADRS) Duration of Response</measure>
    <time_frame>Baseline up to 12 Months</time_frame>
    <description>Duration of MADRS response, defined as the number of consecutive months from first observed MADRS response to the first assessment of MADRS response relapse.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Montgomery Åsberg Depression Rating Scale (MADRS) Rate of Remission</measure>
    <time_frame>Baseline up to 12 Months</time_frame>
    <description>The rate of remission is defined as total number of months in remission divided by total months of expected study participation. Subjects discontinuing the study before the endpoint assessment will be considered as non-in-remission for each successive month after discontinuance</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Montgomery Åsberg Depression Rating Scale (MADRS) Maximum duration of Response</measure>
    <time_frame>Baseline up to 12 Months</time_frame>
    <description>Maximum duration of MADRS response, defined as the maximum number of consecutive months in response (only for subjects experiencing MADRS response).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Montgomery Åsberg Depression Rating Scale (MADRS) Duration of Remission</measure>
    <time_frame>Baseline up to 12 Months</time_frame>
    <description>Duration of MADRS remission, defined as the number of consecutive months from first observed MADRS remission to the first assessment of MADRS remission relapse (defined score &gt; 20).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Montgomery Åsberg Depression Rating Scale (MADRS) Maximum duration of Remission</measure>
    <time_frame>Baseline up to 12 Months</time_frame>
    <description>Maximum duration of MADRS remission, defined as the maximum number of consecutive months in remission (only for subjects experiencing MADRS remission).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assess all Adverse Events</measure>
    <time_frame>Implant to 12 Months</time_frame>
    <description>All adverse events, with a focus on device or procedure-related serious adverse events.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>WHO Disability Assessment Schedule (WHODAS) Changes in scores over time</measure>
    <time_frame>Baseline to 12 Months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Health Outcome Scale (EQ-5D-L) Changes in scores over time</measure>
    <time_frame>Baseline to 12 Months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical Global Impressions Scale - Improvement (CGI-I) Response</measure>
    <time_frame>12 months post randomization</time_frame>
    <description>A CGI-I score ≤ 2 at 12 months from randomization. Subjects discontinuing the study before the 12 months assessment will be considered as not in response for each successive month after discontinuance.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sheehan Suicidality Tracking Scale (S-STS) Changes in Suicidality</measure>
    <time_frame>Implant to 12 Months</time_frame>
    <description>Suicide attempts as measured by items #10 &amp; #12 in S-STS scale</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">6800</enrollment>
  <condition>Treatment Resistant Depression</condition>
  <arm_group>
    <arm_group_label>Active</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group will have VNS activated 2 weeks post implant.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Group will be implanted with VNS but device is not activated for the first 12 months. After 12 months, this group can receive stimulation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Vagus Nerve Stimulation (VNS)</intervention_name>
    <description>VNS is an implantable device that delivers stimulation to the vagal nerve.</description>
    <arm_group_label>Active</arm_group_label>
    <arm_group_label>Control</arm_group_label>
    <other_name>VNS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        The patient must be in a major depressive disorder (MDD) episode for ≥ two years or have&#xD;
        had at least four episodes of MDD, including the current episode.&#xD;
&#xD;
        The patient's depressive illness meets a minimum criterion of four prior failed treatments&#xD;
        of adequate dose and duration as measured by a tool designed for this purpose.&#xD;
&#xD;
        The patient is experiencing a major depressive episode (MDE) as measured by a guideline&#xD;
        recommended depression scale assessment tool on two visits, within a 45-day span prior to&#xD;
        implantation of the VNS device.&#xD;
&#xD;
        Patients must maintain a stable medication regimen for at least four weeks before device&#xD;
        implantation.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Current or lifetime history of psychotic features in any MDE;&#xD;
&#xD;
        Current or lifetime history of schizophrenia or schizoaffective disorder;&#xD;
&#xD;
        Current or lifetime history of any other psychotic disorder;&#xD;
&#xD;
        Current or lifetime history of rapid cycling bipolar disorder;&#xD;
&#xD;
        Current secondary diagnosis of delirium, dementia, amnesia, or other cognitive disorder;&#xD;
&#xD;
        Current suicidal intent; or&#xD;
&#xD;
        Treatment with another investigational device or investigational drugs.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Charles Conway, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laura Yates, BSN</last_name>
    <phone>281-228-7433</phone>
    <email>laura.yates@livanova.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jeff Way, BS</last_name>
    <phone>281-228-7394</phone>
    <email>jeffrey.way@livanova.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katlyn Jackson</last_name>
      <phone>205-975-6426</phone>
      <email>katlynjackson@uabmc.edu</email>
    </contact>
    <investigator>
      <last_name>Matthew Macaluso, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Access Multi Specialty Medical Clinic, Inc</name>
      <address>
        <city>Burlingame</city>
        <state>California</state>
        <zip>94010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Levinson, MD</last_name>
      <phone>415-857-1151</phone>
      <email>mlevinsonmd@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Michael Levinson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CMB Clinical Trials</name>
      <address>
        <city>Colton</city>
        <state>California</state>
        <zip>92324</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>ATP Clinical Research, Inc.</name>
      <address>
        <city>Costa Mesa</city>
        <state>California</state>
        <zip>92626</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bobby Shih</last_name>
      <phone>714-277-4472</phone>
      <email>bshih@atpcr.com</email>
    </contact>
    <investigator>
      <last_name>Gustavo Alva, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rodney Rivera</last_name>
      <phone>619-543-6446</phone>
      <email>rrivera@ucsd.edu</email>
    </contact>
    <investigator>
      <last_name>Mounir Soliman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>SF-CARE, Inc.</name>
      <address>
        <city>San Rafael</city>
        <state>California</state>
        <zip>94901</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seema Bangalore</last_name>
      <phone>415-747-8474</phone>
      <email>seema@sf-care.com</email>
    </contact>
    <investigator>
      <last_name>Jason Bermak, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Syrentis Clinical Research</name>
      <address>
        <city>Santa Ana</city>
        <state>California</state>
        <zip>92705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jonathan Barber</last_name>
      <phone>714-542-3008</phone>
      <phone_ext>308</phone_ext>
      <email>JBarber@syrentis.com</email>
    </contact>
    <investigator>
      <last_name>Thomas Schwartz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mindful Behavioral Health</name>
      <address>
        <city>Boca Raton</city>
        <state>Florida</state>
        <zip>33431</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashley Stepler</last_name>
      <phone>561-499-6933</phone>
      <email>astepler@gminstitutes.com</email>
    </contact>
    <investigator>
      <last_name>Ivan Cichowicz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medycal Research, Inc</name>
      <address>
        <city>Brooksville</city>
        <state>Florida</state>
        <zip>34609</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>Galiz Research LLC</name>
      <address>
        <city>Hialeah</city>
        <state>Florida</state>
        <zip>33016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yohana Lima</last_name>
      <phone>305-805-0921</phone>
      <email>yohana@galizresearch.com</email>
    </contact>
    <investigator>
      <last_name>Jose Gamez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Segal Trials Corporate</name>
      <address>
        <city>Lauderhill</city>
        <state>Florida</state>
        <zip>33319</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fedor Richani</last_name>
      <phone>954-990-6326</phone>
      <email>frichani@segaltrials.com</email>
    </contact>
    <contact_backup>
      <last_name>Courtney Talbert</last_name>
      <phone>954-990-6326</phone>
      <email>ctalbert@segaltrials.com</email>
    </contact_backup>
    <investigator>
      <last_name>Rishi Kakar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ocean Blue Medical Research Center</name>
      <address>
        <city>Miami Springs</city>
        <state>Florida</state>
        <zip>33166</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yanet R Ferrera</last_name>
      <phone>305-885-8983</phone>
      <email>yanet.ferrera@obmedresearch.com</email>
    </contact>
    <investigator>
      <last_name>Richard Dreize, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Central Miami Medical Institute, LLC</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33125</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Ocana</last_name>
      <phone>305-547-2011</phone>
      <email>mocana@gminstitutes.com</email>
    </contact>
    <investigator>
      <last_name>Leonardo Alonso, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clintex Research Group, Inc.</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33135</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raul Pardo</last_name>
      <phone>305-597-3929</phone>
      <email>rpardo@clintexresearch.com</email>
    </contact>
    <investigator>
      <last_name>Manuel Melendez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Research Center Of Florida, Inc</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33135</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Damian Beltran-Garces</last_name>
      <phone>305-603-8844</phone>
      <email>dgarces@doctor.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>APG Research, LLC</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matt Bubal</last_name>
      <phone>407-808-1875</phone>
      <email>apgresearch.bubalo@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Morteza Nadjafi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Millenia Psychiatry &amp; Research, Inc</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32819</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Santosh Pillai (PI), DO</last_name>
      <phone>407-830-0414</phone>
      <email>santoshpillaido@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Santosh Pillai, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Quantum Laboratories Inc.</name>
      <address>
        <city>Pompano Beach</city>
        <state>Florida</state>
        <zip>33064</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karen Herr, MD</last_name>
      <phone>954-933-2324</phone>
      <email>quantumres2@quantum-lab.com</email>
    </contact>
    <investigator>
      <last_name>Jose De La Gandara, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Advanced Mental Health Care Inc.</name>
      <address>
        <city>Royal Palm Beach</city>
        <state>Florida</state>
        <zip>33411</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elyssa Sisko</last_name>
      <phone>561-333-8884</phone>
      <email>Amhc.phones@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Aron Tendler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Florida Center for TMS</name>
      <address>
        <city>Saint Augustine</city>
        <state>Florida</state>
        <zip>94901</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jason R Fritz</last_name>
      <phone>850-212-6262</phone>
      <email>jfritz01@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Heather Luing, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stedman Clinical Trials</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33613</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Fowler</last_name>
      <phone>813-971-8311</phone>
      <email>susan_fowler@stedmanclinicaltrials.com</email>
    </contact>
    <investigator>
      <last_name>Mary L Stedman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Psychiatric Specialty Center</name>
      <address>
        <city>West Palm Beach</city>
        <state>Florida</state>
        <zip>33409</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donna Cipriani</last_name>
      <phone>561-331-8800</phone>
      <email>dcipriani@pscpalmbeach.com</email>
    </contact>
    <investigator>
      <last_name>Amanda Darling, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sinéad Quinn</last_name>
      <phone>404-727-9228</phone>
      <email>scquinn@emory.edu</email>
    </contact>
    <investigator>
      <last_name>Patricio Riva Posse, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>PACT Atlanta LLC</name>
      <address>
        <city>Decatur</city>
        <state>Georgia</state>
        <zip>30030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paige Hayduk</last_name>
      <phone>678-860-6580</phone>
      <email>paigehayduk1@gamil.com</email>
    </contact>
    <contact_backup>
      <last_name>Wanda Serrano</last_name>
      <phone>787-232-2530</phone>
      <email>wserrano@umhs-sk.net</email>
    </contact_backup>
    <investigator>
      <last_name>Todd Antin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IACT Health</name>
      <address>
        <city>Grayson</city>
        <state>Georgia</state>
        <zip>30017</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Psych Atlanta</name>
      <address>
        <city>Marietta</city>
        <state>Georgia</state>
        <zip>30060</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Kane</last_name>
      <phone>770-422-2846</phone>
      <email>jenniferk@nbmedicine.com</email>
    </contact>
    <investigator>
      <last_name>Michael Banov, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pearl Health Clinic</name>
      <address>
        <city>Ammon</city>
        <state>Idaho</state>
        <zip>83406</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Knutson</last_name>
      <phone>208-346-7500</phone>
      <phone_ext>300</phone_ext>
      <email>jknutson@pearlhealth.org</email>
    </contact>
    <investigator>
      <last_name>Cristina Sanchez-Jaquez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Joliet Center For Clinical Research</name>
      <address>
        <city>Joliet</city>
        <state>Illinois</state>
        <zip>60435</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cosme Lozano (PI), MD</last_name>
      <phone>815-729-7790</phone>
      <email>cosme.lozano@jolietcenter.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>AMR- Baber Research, Inc.</name>
      <address>
        <city>Naperville</city>
        <state>Illinois</state>
        <zip>60563</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tina Marzullo</last_name>
      <phone>630-844-2095</phone>
      <email>tina@baberresearchgroup.com</email>
    </contact>
    <investigator>
      <last_name>Riaz Baber, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Psychiatric Medicine Associates, LLC</name>
      <address>
        <city>Skokie</city>
        <state>Illinois</state>
        <zip>60076</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amanda White</last_name>
      <phone>847-679-8000</phone>
      <phone_ext>12</phone_ext>
      <email>awhite.pma@gmail.com</email>
    </contact>
    <investigator>
      <last_name>John Zajecka, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Southern Illinois University School of Medicine</name>
      <address>
        <city>Springfield</city>
        <state>Illinois</state>
        <zip>62794</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vineela Sunkepalli</last_name>
      <phone>217-545-7321</phone>
      <email>vsunkepalli85@siumed.edu</email>
    </contact>
    <investigator>
      <last_name>Jeffrey Bennett, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Neuroscience Research Institute</name>
      <address>
        <city>Winfield</city>
        <state>Illinois</state>
        <zip>60910</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Advanced Research Institute, Inc.</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>56268</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christina Tyson</last_name>
      <phone>727-835-3261</phone>
      <email>christina.arel@ariclinical.com</email>
    </contact>
    <investigator>
      <last_name>Prasanna Chinthala, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beacon Medical Group Behavioral Health</name>
      <address>
        <city>South Bend</city>
        <state>Indiana</state>
        <zip>46601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vanessa DePue, RN</last_name>
      <phone>574-647-6584</phone>
      <email>Vdepue@beaconhealthsystem.org</email>
    </contact>
    <investigator>
      <last_name>Ahmed Elmaadawi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Of Kansas Cancer Center</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>Sheppard Pratt Health System, Inc.</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brittany Troen</last_name>
      <phone>410-938-3139</phone>
      <email>btroen@sheppardpratt.org</email>
    </contact>
    <investigator>
      <last_name>Scott Aaronson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinical Insights</name>
      <address>
        <city>Glen Burnie</city>
        <state>Maryland</state>
        <zip>21061</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Norhan Ibrahim</last_name>
      <phone>410-768-2629</phone>
      <email>ibrahim@clinicalinsights.com</email>
    </contact>
    <contact_backup>
      <last_name>Lawrence Adler (PI), MD</last_name>
      <phone>410-768-9072</phone>
      <email>adler@clinicalinsights.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Megha Nagaswami</last_name>
      <phone>617-724-7244</phone>
      <email>MNAGASWAMI@mgh.harvard.edu</email>
    </contact>
    <contact_backup>
      <last_name>Emily Tan</last_name>
      <email>ektan@mgh.harvard.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Cristina Cusin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Michigan Clinical Research Institute PC</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amanda Szczesniak</last_name>
      <phone>734-834-8954</phone>
      <phone_ext>2</phone_ext>
      <email>amandas@earlytreatment.org</email>
    </contact>
    <investigator>
      <last_name>Rajaprabhakaran Rajarethinam, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Minnesota</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55416</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maxwell Thorpe</last_name>
      <phone>952-525-4505</phone>
      <email>thorp131@umn.edu</email>
    </contact>
    <investigator>
      <last_name>Ziad Nahas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Precise Research Centers</name>
      <address>
        <city>Flowood</city>
        <state>Mississippi</state>
        <zip>39232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katherine Fickert</last_name>
      <phone>601-420-5810</phone>
      <email>kfickert@precise-research.com</email>
    </contact>
    <investigator>
      <last_name>Joseph Kwentus, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Missouri</name>
      <address>
        <city>Columbia</city>
        <state>Missouri</state>
        <zip>65212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew Schmidt</last_name>
      <phone>573-882-5688</phone>
      <email>schmidtmw@health.missouri.edu</email>
    </contact>
    <investigator>
      <last_name>Muaid Ithman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Psychiatric Care and Research</name>
      <address>
        <city>O'Fallon</city>
        <state>Missouri</state>
        <zip>633668</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Beth Haug</last_name>
      <phone>636-244-3593</phone>
      <email>mhaug@pcrc-stl.com</email>
    </contact>
    <investigator>
      <last_name>John Canale, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>PsychCare Consultants Research</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63128</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anita Broeker</last_name>
      <phone>314-849-1853</phone>
      <phone_ext>203</phone_ext>
      <email>anita.broeker@pccresearch.org</email>
    </contact>
    <investigator>
      <last_name>Mohd Malik, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Alivation Research, LLC</name>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>68526</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelly Espenschade</last_name>
      <phone>402-817-2235</phone>
      <email>KEspenschade@alivation.com</email>
    </contact>
    <investigator>
      <last_name>Walter Duffy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of New Mexico - Psychiatric Center</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Erie County Medical Center/State University of New York (SUNY) at Buffalo Affiliate</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sevie Kandefer</last_name>
      <phone>716-898-4038</phone>
      <email>sk293@buffalo.edu</email>
    </contact>
    <investigator>
      <last_name>Biswarup Ghosh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Trinity Medical</name>
      <address>
        <city>Lewiston</city>
        <state>New York</state>
        <zip>14092</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Theresa Giambra</last_name>
      <phone>716-204-1950</phone>
      <email>tgiambra@trinitymedicalwny.org</email>
    </contact>
    <investigator>
      <last_name>Alfred Belen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hapworth Research Inc.</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10019</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mariah Garcia</last_name>
      <phone>212-956-2000</phone>
      <email>mgarcia@treatmentonline.com</email>
    </contact>
    <investigator>
      <last_name>William Hapworth, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Icahn School of Medicine at Mount Sinai</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emma Meyer, MD</last_name>
      <phone>212-585-4640</phone>
      <email>emma.meyer@mssm.edu</email>
    </contact>
    <investigator>
      <last_name>James M Murrough, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Richmond Behavioral Associates</name>
      <address>
        <city>Staten Island</city>
        <state>New York</state>
        <zip>10312</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Stony Brook University Hospital</name>
      <address>
        <city>Stony Brook</city>
        <state>New York</state>
        <zip>11794</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan M. Fiore</last_name>
      <phone>631-444-9425</phone>
      <email>Susan.Fiore@stonybrookmedicine.edu</email>
    </contact>
    <investigator>
      <last_name>Lucian Manu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>State University Of New York Upstate Medical University</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Schwartz (PI), MD</last_name>
      <phone>315-464-3166</phone>
      <email>schwartt@upstate.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wake Forest University Health Science</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>The Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Savannah Headley</last_name>
      <phone>716-818-9635</phone>
      <email>tgiambra@trinitymedicalwny.org</email>
    </contact>
    <investigator>
      <last_name>Kevin Reeves, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Signature Research Associates, Inc.</name>
      <address>
        <city>Fairlawn</city>
        <state>Ohio</state>
        <zip>44333</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carl Faust</last_name>
      <phone>330-835-4000</phone>
      <email>faust.carl@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Anand Chaturvedi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Charak Center for Health and Wellness</name>
      <address>
        <city>Garfield Heights</city>
        <state>Ohio</state>
        <zip>44125</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Manuel</last_name>
      <phone>216-587-6727</phone>
      <phone_ext>Option 5</phone_ext>
      <email>mmanuel@charakresearch.com</email>
    </contact>
    <investigator>
      <last_name>Rakesh Ranjan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NPC Research</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73109-3834</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Rivus Wellness &amp; Research Institute</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marvin Peyton (PI), MD</last_name>
      <phone>405-753-4994</phone>
      <email>drpeyton@rivusinstitute.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Scranton Medical Institutes</name>
      <address>
        <city>Moosic</city>
        <state>Pennsylvania</state>
        <zip>18507</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christina Kane</last_name>
      <phone>570-346-3686</phone>
      <phone_ext>172</phone_ext>
      <email>ckane@gminstitutes.com</email>
    </contact>
    <investigator>
      <last_name>Matthew Berger, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adna Jaganjac</last_name>
      <phone>215-573-4561</phone>
      <email>Adna.Jaganjac@pennmedicine.upenn.edu</email>
    </contact>
    <investigator>
      <last_name>Yvett Sheline, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Morgan Dancy</last_name>
      <phone>843-876-5141</phone>
      <email>maddoxm@musc.edu</email>
    </contact>
    <investigator>
      <last_name>Mark George, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Neuroscience and TMS Treatment Center</name>
      <address>
        <city>Brentwood</city>
        <state>Tennessee</state>
        <zip>37027</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lauren Valencia</last_name>
      <phone>615-224-9800</phone>
      <phone_ext>2</phone_ext>
      <email>Valencia@hopeforyourbrain.com</email>
    </contact>
    <investigator>
      <last_name>Jonathan Becker, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UT Health Austin, Mulva Clinic for the Neurosciences</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78712</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicole Bernal</last_name>
      <phone>833-882-2737</phone>
      <email>nicole.bernal@austin.utexas.edu</email>
    </contact>
    <investigator>
      <last_name>Jorge Almeida, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>BioBehavioral Research of Austin</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78759</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Candice Peel</last_name>
      <phone>512-382-6661</phone>
      <email>candice@bbraustin.com</email>
    </contact>
    <investigator>
      <last_name>Charles Sweet, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Texas Tech University Health Science Center</name>
      <address>
        <city>El Paso</city>
        <state>Texas</state>
        <zip>79905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Thompson (PI), MD</last_name>
      <phone>915-215-5850</phone>
      <email>pm.thompson@ttuhsc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The University Of Texas Medical School At Houston - UT Center Of Excellence On Mood Disorders</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77054</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Flavio Nascimento e Silva, MD, MD</last_name>
      <phone>713-486-2548</phone>
      <email>Flavio.NascimentoeSilva@uth.tmc.edu</email>
    </contact>
    <investigator>
      <last_name>Joao De Quevedo, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northpointe Psychiatry</name>
      <address>
        <city>Lewisville</city>
        <state>Texas</state>
        <zip>75057</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Asad Islam (PI), MD</last_name>
      <phone>214-799-8277</phone>
      <email>northpointe.research@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rise Clinical Research, LLC</name>
      <address>
        <city>Missouri City</city>
        <state>Texas</state>
        <zip>77459</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Prashant Gajwani (PI), MD</last_name>
      <phone>281-778-9530</phone>
      <email>drgajwani@riseclinicalresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brian Mickey (PI), MD, PhD</last_name>
      <phone>801-587-3297</phone>
    </contact>
    <contact_backup>
      <last_name>Rebecca Jacobs</last_name>
      <phone>(801) 829-7382</phone>
      <email>Rebecca.Jacobs@utah.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Neuropsychiatric Associates, Plc</name>
      <address>
        <city>Woodstock</city>
        <state>Vermont</state>
        <zip>05091</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Shaw</last_name>
      <phone>802-457-4904</phone>
      <email>sshaw@woodstockresearch.org</email>
    </contact>
    <investigator>
      <last_name>Susan Smiga, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Carilion Clinic</name>
      <address>
        <city>Roanoke</city>
        <state>Virginia</state>
        <zip>24014</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bryce Lewis</last_name>
      <phone>540-494-8285</phone>
      <email>brlewis@carilionclinic.org</email>
    </contact>
    <investigator>
      <last_name>Anita Kablinger, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Center For Anxiety and Depression</name>
      <address>
        <city>Mercer Island</city>
        <state>Washington</state>
        <zip>98040</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David L Dunner (PI), MD</last_name>
      <phone>206-230-0330</phone>
      <email>dldunner@comcast.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Seattle Neuropsychiatric Treatment Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hannah Beasley, MD</last_name>
      <phone>206-467-6300</phone>
      <email>info@seattlentc.com</email>
    </contact>
    <investigator>
      <last_name>Rebecca Allen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>West Virginia Clinical and Translational Science Institute</name>
      <address>
        <city>Morgantown</city>
        <state>West Virginia</state>
        <zip>26506</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine O'Dell</last_name>
      <phone>304-581-1751</phone>
      <email>Catherine.Odell1@hsc.wvu.edu</email>
    </contact>
    <investigator>
      <last_name>Patrick Marshalek, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=292</url>
    <description>CMS Decision Memo for Vagus Nerve Stimulation (VNS) for Treatment Resistant Depression</description>
  </link>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>March 21, 2019</study_first_submitted>
  <study_first_submitted_qc>March 21, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 25, 2019</study_first_posted>
  <last_update_submitted>September 14, 2021</last_update_submitted>
  <last_update_submitted_qc>September 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>VNS</keyword>
  <keyword>Depression</keyword>
  <keyword>TRD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depressive Disorder, Treatment-Resistant</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

